Skip to content

Communicating Evidence From Systematic Reviews to the Public

Communicating Evidence From Systematic Reviews to the Public: A Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01939925
Acronym
PLSRCT
Enrollment
193
Registered
2013-09-11
Start date
2009-05-31
Completion date
2009-10-31
Last updated
2013-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult

Keywords

patient education, Health Knowledge, Attitudes, Practice, comprehension, consumer health information

Brief summary

The purpose of this randomised controlled trial is to compare a new standardised summary format for presentation of synthesised evidence from systematic reviews for the public (a new plain language summary format) to the current format used in Cochrane systematic reviews. The study will evaluate if the new presentation improves understanding about the benefits and harms of an intervention, if it improves the accessibility of the information, and if it is preferred over other versions by the public over the current format.

Interventions

OTHERNew plain language summary format

New plain language summary includes qualitative and quantitative description of text (absolute effects and natural frequencies provided); quantitative results provided in a table; quality of the evidence according to GRADE provided in a table; question and answer format; follows principles of linguistic frameworks (e.g. progressive movements from introduction to 'bottom line')

OTHERCurrent plain language summary format

Current plain language summary includes qualitative description of effects only; inconsistent description of the quality of the evidence; paragraph of text; inconsistent flow of information

Sponsors

McMaster University
CollaboratorOTHER
University of Ottawa
CollaboratorOTHER
Asociacion Colaboracion Cochrane Iberoamericana
CollaboratorOTHER
University of Milan
CollaboratorOTHER
Norwegian Knowledge Centre for the Health Services
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* patients or members of the public 16 years or older

Design outcomes

Primary

MeasureTime frameDescription
Understanding of benefits and harmsAfter reading summary - time 0Average proportion of people who answered 5 multiple choice questions correctly. Each question includes five response options about the number of people who could benefit or be harmed by the intervention and about the quality of evidence

Secondary

MeasureTime frameDescription
Number of questions answered correctlyAfter reading summary - time 0Total number of questions out of five questions for benefits and harms that were answered correctly

Other

MeasureTime frameDescription
Understanding of the purpose of the summaryafter reading summary - time 0A multiple choice question with three options
Understanding the producer of the summaryafter reading summary - time 0A multiple choice question with three options
Usability and accessibilityafter reading summary - time 0Five questions about whether information was easy to find and understand, reliable, and useful to someone making a decision. Measured using a 7 point Likert scale (strongly agree to strongly disagree).
Preference for the new format or the old formatafter reading both summaries - time 07 point likert scale

Countries

Argentina, Canada, Italy, Norway, Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026